143 related articles for article (PubMed ID: 2013529)
1. Effects of carbamazepine and valproate on immunological assessment in young epileptic patients.
Lenti C; Masserini C; Peruzzi C; Guareschi Cazzullo A
Ital J Neurol Sci; 1991 Feb; 12(1):87-91. PubMed ID: 2013529
[TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.
Başaran N; Hincal F; Kansu E; Ciğer A
Int J Immunopharmacol; 1994 Dec; 16(12):1071-7. PubMed ID: 7705969
[TBL] [Abstract][Full Text] [Related]
3. Color vision in epileptic adolescents treated with valproate and carbamazepine.
Verrotti A; Lobefalo L; Priolo T; Rapinese M; Trotta D; Morgese G; Gallenga PE; Chiarelli F
Seizure; 2004 Sep; 13(6):411-7. PubMed ID: 15276145
[TBL] [Abstract][Full Text] [Related]
4. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
[TBL] [Abstract][Full Text] [Related]
5. Color vision and macular recovery time in epileptic adolescents treated with valproate and carbamazepine.
Verrotti A; Lobefalo L; Tocco AM; Spalice A; Gallenga PE; Chiarelli F; Iannetti P
Eur J Neurol; 2006 Jul; 13(7):736-41. PubMed ID: 16834703
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins in children with epilepsy: the Dutch Study of Epilepsy in Childhood.
Callenbach PM; Jol-Van Der Zijde CM; Geerts AT; Arts WF; Van Donselaar CA; Peters AC; Stroink H; Brouwer OF; Van Tol MJ;
Clin Exp Immunol; 2003 Apr; 132(1):144-51. PubMed ID: 12653849
[TBL] [Abstract][Full Text] [Related]
7. Sodium valproate and valpromide: differential interactions with carbamazepine in epileptic patients.
Pisani F; Fazio A; Oteri G; Ruello C; Gitto C; Russo F; Perucca E
Epilepsia; 1986; 27(5):548-52. PubMed ID: 3093212
[TBL] [Abstract][Full Text] [Related]
8. Salivary immunoglobulin concentrations in patients with epilepsy treated with carbamazepine.
Gilhus NE; Strandjord RE; Aarli JA
Acta Neurol Scand; 1980 Nov; 62(5):300-4. PubMed ID: 7468153
[TBL] [Abstract][Full Text] [Related]
9. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
[TBL] [Abstract][Full Text] [Related]
10. Epileptic patients refractory to drug therapy.
Paris L; Giardina M; Pacifici R; Pichini S; Zuccaro P; Sideri G
Ital J Neurol Sci; 1991 Oct; 12(5):447-51. PubMed ID: 1955301
[TBL] [Abstract][Full Text] [Related]
11. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
Tumay Y; Altun Y; Ekmekci K; Ozkul Y
Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
[TBL] [Abstract][Full Text] [Related]
12. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
[TBL] [Abstract][Full Text] [Related]
13. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
Steinborn B; Galas-Zgorzalewicz B
Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
[TBL] [Abstract][Full Text] [Related]
14. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
Vainionpää LK; Mikkonen K; Rättyä J; Knip M; Pakarinen AJ; Myllylä VV; Isojärvi JI
Epilepsia; 2004 Mar; 45(3):197-203. PubMed ID: 15009219
[TBL] [Abstract][Full Text] [Related]
15. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy.
Verrotti A; Basciani F; Trotta D; Pomilio MP; Morgese G; Chiarelli F
Epilepsy Res; 2002 Jan; 48(1-2):71-5. PubMed ID: 11823111
[TBL] [Abstract][Full Text] [Related]
16. Vascular function and risk factors in children with epilepsy: associations with sodium valproate and carbamazepine.
Keenan N; Sadlier LG; Wiltshire E
Epilepsy Res; 2014 Aug; 108(6):1087-94. PubMed ID: 24893830
[TBL] [Abstract][Full Text] [Related]
17. Thyroid function and volume in epileptic children using carbamazepine, oxcarbazepine and valproate.
Hirfanoglu T; Serdaroglu A; Camurdan O; Cansu A; Bideci A; Cinaz P; Gucuyener K
Pediatr Int; 2007 Dec; 49(6):822-6. PubMed ID: 18045279
[TBL] [Abstract][Full Text] [Related]
18. Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children.
Cepelak I; Zanić Grubisić T; Mandusić A; Rekić B; Lenicek J
Clin Chim Acta; 1998 Aug; 276(2):121-7. PubMed ID: 9764730
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine.
Verrotti A; Pascarella R; Trotta D; Giuva T; Morgese G; Chiarelli F
Epilepsy Res; 2000 Oct; 41(3):253-7. PubMed ID: 10962216
[TBL] [Abstract][Full Text] [Related]
20. The effects of valproate, carbamazepine, and oxcarbazepine on growth and sexual maturation in girls with epilepsy.
Rättyä J; Vainionpää L; Knip M; Lanning P; Isojärvi JI
Pediatrics; 1999 Mar; 103(3):588-93. PubMed ID: 10049961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
